Phase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma
Year: 2003
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: hepatocellular carcinoma, fibrolamellar hepatocellular carcinoma, 5-fluorouracil, interferon alfa-2b, subcutaneous interferon, liver cirrhosis, combination chemotherapy, tumor response, survival, toxicity, stomatitis, orthotopic liver transplantation, hepatectomy, surgical margins, complete response, partial response, hematologic toxicity
Open Access status: closed
OpenAlex ID: W2050565603
